| [1] |
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3)：209-249.
|
| [2] |
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6)：394-424.
|
| [3] |
Hankinson SE, Colditz GA, Willett WC. Towards an integrated model for breast cancer etiology: the lifelong interplay of genes, lifestyle, and hormones[J]. Breast Cancer Res, 2004, 6(5)：213-218.
|
| [4] |
Cao S, Lu S, Zhou J, et al. Association between dietary patterns and risk of breast cancer in chinese female population: a latent class analysis[J]. Public Health Nutr, 2021, 24(15)：4918-4928.
|
| [5] |
Gram IT, Park SY, Maskarinec G, et al. Smoking and breast cancer risk by race/ethnicity and oestrogen and progesterone receptor status: the multiethnic cohort (MEC) study[J]. Int J Epidemiol, 2019, 48(2)：501-511.
|
| [6] |
Hastert TA, Beresford SA, Sheppard L, et al. Disparities in cancer incidence and mortality by area-level socioeconomic status: a multilevel analysis[J]. J Epidemiol Community Health, 2015, 69(2)：168-176.
|
| [7] |
Madigan MP, Ziegler RG, Benichou J, et al. Proportion of breast cancer cases in the united states explained by well-established risk factors[J]. J Natl Cancer Inst, 1995, 87(22)：1681-1685.
|
| [8] |
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Painting, firefighting, and shiftwork[J]. IARC Monogr Eval Carcinog Risks Hum, 2010, 98：9-764.
|
| [9] |
Gentry NW, Ashbrook LH, Fu YH, et al. Human circadian variations[J]. J Clin Invest, 2021, 131(16)：e148 282.
|
| [10] |
Sulli G, Lam MTY, Panda S. Interplay between circadian clock and cancer: new frontiers for cancer treatment[J]. Trends Cancer, 2019, 5(8)：475-494.
|
| [11] |
Saper CB. The central circadian timing system[J]. Curr Opin Neurobiol, 2013, 23(5)：747-751.
|
| [12] |
Duffy JF, Czeisler CA. Effect of light on human circadian physiology[J]. Sleep Med Clin, 2009, 4(2)：165-177.
|
| [13] |
Van Dycke KC, Rodenburg W, van Oostrom CT, et al. Chronically alternating light cycles increase breast cancer risk in mice[J]. Curr Biol, 2015, 25(14)：1932-1937.
|
| [14] |
Hadadi E, Taylor W, Li XM, et al. Chronic circadian disruption modulates breast cancer stemness and immune microenvironment to drive metastasis in mice[J]. Nat Commun, 2020, 11(1)：3193.
|
| [15] |
Filipski E, Delaunay F, King VM, et al. Effects of chronic jet lag on tumor progression in mice[J]. Cancer Res, 2004, 64(21)：7879-7885.
|
| [16] |
Parent-Thirion A, Biletta I, Cabrita J, et al. 6th European working conditions survey: overview report [EB/OL]. [2022-05-18].
URL
|
| [17] |
Szkiela M, Kusideł E, Makowiec-Dᶏbrowska T, et al. Night shift work-a risk factor for breast cancer[J]. Int J Environ Res Public Health, 2020, 17(2)：659.
|
| [18] |
Schwarz C, Pedraza-Flechas AM, Pastor-Barriuso R, et al. Long-term nightshift work and breast cancer risk: an updated systematic review and meta-analysis with special attention to menopausal status and to recent nightshift work[J]. Cancers (Basel), 2021, 13(23)：5952.
|
| [19] |
Cordina-Duverger E, Menegaux F, Popa A, et al. Night shift work and breast cancer: a pooled analysis of population-based case-control studies with complete work history[J]. Eur J Epidemiol, 2018, 33(4)：369-379.
|
| [20] |
Wang P, Ren FM, Lin Y, et al. Night-shift work, sleep duration, daytime napping, and breast cancer risk[J]. Sleep Med, 2015, 16(4)：462-468.
|
| [21] |
Papantoniou K, Castaño-Vinyals G, Espinosa A, et al. Breast cancer risk and night shift work in a case-control study in a Spanish population[J]. Eur J Epidemiol, 2016, 31(9)：867-878.
|
| [22] |
Sweeney MR, Sandler DP, Niehoff NM, et al. Shift work and working at night in relation to breast cancer incidence[J]. Cancer Epidemiol Biomarkers Prev, 2020, 29(3)：687-689.
|
| [23] |
Jones ME, Schoemaker MJ, McFadden EC, et al. Night shift work and risk of breast cancer in women: the generations study cohort[J]. Br J Cancer, 2019, 121(2)：172-179.
|
| [24] |
Åkerstedt T, Knutsson A, Narusyte J, et al. Night work and breast cancer in women: a Swedish cohort study[J]. BMJ Open, 2015, 5(4)：e008 127.
|
| [25] |
Travis RC, Balkwill A, Fensom GK, et al. Night shift work and breast cancer incidence: three prospective studies and meta-analysis of published studies[J]. J Natl Cancer Inst, 2016, 108(12): djw169.
|
| [26] |
Wegrzyn LR, Tamimi RM, Rosner BA, et al. Rotating night-shift work and the risk of breast cancer in the nurses’ health studies[J]. Am J Epidemiol, 2017, 186(5)：532-540.
|
| [27] |
Schoemaker MJ, Nichols HB, Wright LB, et al. Association of body mass index and age with subsequent breast cancer risk in premenopausal women[J]. JAMA Oncol, 2018, 4(11)：e181 771.
|
| [28] |
Bhattacharya S, Patel KK, Dehari D, et al. Melatonin and its ubiquitous anticancer effects[J]. Mol Cell Biochem, 2019, 462(1-2)：133-155.
|
| [29] |
Chang AM, Aeschbach D, Duffy JF, et al. Evening use of light-emitting ereaders negatively affects sleep, circadian timing, and next-morning alertness[J]. Proc Natl Acad Sci USA, 2015, 112(4)：1232-1237.
|
| [30] |
Nagata C, Nagao Y, Yamamoto S, et al. Light exposure at night, urinary 6-sulfatoxymelatonin, and serum estrogens and androgens in postmenopausal Japanese women[J]. Cancer Epidemiol Biomarkers Prev, 2008, 17(6)：1418-1423.
|
| [31] |
Wong ATY, Fensom GK, Key TJ, et al. Urinary melatonin in relation to breast cancer risk: nested case-control analysis in the DOM study and meta-analysis of prospective studies[J]. Cancer Epidemiol Biomarkers Prev, 2021, 30(1)：97-103.
|
| [32] |
Xiao Q, Gierach GL, Bauer C, et al. The association between outdoor artificial light at night and breast cancer risk in black and white women in the southern community cohort study[J]. Environ Health Perspect, 2021, 129(8)：87 701.
|
| [33] |
Clarke RB, Amini H, James P, et al. Outdoor light at night and breast cancer incidence in the danish nurse cohort[J]. Environ Res, 2021, 194：110 631.
|
| [34] |
Xiao Q, James P, Breheny P, et al. Outdoor light at night and postmenopausal breast cancer risk in the NIH-AARP diet and health study[J]. Int J Cancer, 2020, 147(9)：2363-2372.
|
| [35] |
Garcia-Saenz A, Sánchez de Miguel A, Espinosa A, et al. Evaluating the association between artificial light-at-night exposure and breast and prostate cancer risk in spain (MCC-Spain Study)[J]. Environ Health Perspect, 2018, 126(4)：047 011.
|
| [36] |
James P, Bertrand KA, Hart JE, et al. Outdoor light at night and breast cancer incidence in the nurses’ health study Ⅱ[J]. Environ Health Perspect, 2017, 125(8)：087 010.
|
| [37] |
Lai KY, Sarkar C, Ni MY, et al. Exposure to light at night (LAN) and risk of breast cancer: a systematic review and meta-analysis[J]. Sci Total Environ, 2021, 762：143 159.
|
| [38] |
Wu Y, Gui SY, Fang Y, et al. Exposure to outdoor light at night and risk of breast cancer: a systematic review and meta-analysis of observational studies[J]. Environ Pollut, 2021, 269：116 114.
|
| [39] |
Huss A, van Wel L, Bogaards L, et al. Shedding some light in the dark-A comparison of personal measurements with satellite-based estimates of exposure to light at night among children in the netherlands[J]. Environ Health Perspect, 2019, 127(6)：67 001.
|
| [40] |
Borbély A. The two-process model of sleep regulation: beginnings and outlook[J]. J Sleep Res, 2022, 31(4)：e13 598.
|
| [41] |
Hill SM, Belancio VP, Dauchy RT, et al. Melatonin: an inhibitor of breast cancer[J]. Endocr Relat Cancer, 2015, 22(3)：R183-204.
|
| [42] |
Cao J, Eshak ES, Liu K, et al. Sleep duration and risk of breast cancer: the JACC study[J]. Breast Cancer Res Treat, 2019, 174(1)：219-225.
|
| [43] |
Shen J, Chrisman M, Wu X, et al. Sleep duration and risk of cancer in the mexican american mano-a-mano cohort[J]. Sleep Health, 2019, 5(1)：78-83.
|
| [44] |
Soucise A, Vaughn C, Thompson CL, et al. Sleep quality, duration, and breast cancer aggressiveness[J]. Breast Cancer Res Treat, 2017, 164(1)：169-178.
|
| [45] |
Frydenberg H, Thune I, Lofterd T, et al. Pre-diagnostic high-sensitive C-reactive protein and breast cancer risk, recurrence, and survival[J]. Breast Cancer Res Treat, 2016, 155(2)：345-354.
|
| [46] |
Prather AA, Vogelzangs N, Penninx BW. Sleep duration, insomnia, and markers of systemic inflammation: results from the netherlands study of depression and anxiety (NESDA)[J]. J Psychiatr Res, 2015, 60：95-102.
|
| [47] |
Shigesato M, Kawai Y, Guillermo C, et al. Association between sleep duration and breast cancer incidence: The multiethnic cohort[J]. Int J Cancer, 2020, 146(3)：664-670.
|
| [48] |
Wong ATY, Heath AK, Tong TYN, et al. Sleep duration and breast cancer incidence: results from the Million Women Study and meta-analysis of published prospective studies[J]. Sleep, 2021, 44(2)：zsaa166.
|
| [49] |
Girschik J, Fritschi L, Heyworth J, et al. Validation of self-reported sleep against actigraphy[J]. J Epidemiol, 2012, 22(5)：462-468.
|
| [50] |
Hurley S, Goldberg D, Von Behren J, et al. Sleep deficiency and breast cancer risk among postmenopausal women in the california teachers study (CTS)[J]. Cancer Causes Control, 2020, 31(12)：1115-1128.
|
| [51] |
Kong X, Gao R, Wang Z, et al. Melatonin: a potential therapeutic option for breast cancer[J]. Trends Endocrinol Metab, 2020, 31(11)：859-871.
|
| [52] |
Stevens RG, Brainard GC, Blask DE, et al. Breast cancer and circadian disruption from electric lighting in the modern world[J]. CA Cancer J Clin, 2014, 64(3)：207-218.
|
| [53] |
Zhou L, Zhang Z, Nice E, et al. Circadian rhythms and cancers: the intrinsic links and therapeutic potentials[J]. J Hematol Oncol, 2022, 15(1)：1-31.
|
| [54] |
Keshet-Sitton A, Or-Chen K, Yitzhak S, et al. Can avoiding light at night reduce the risk of breast cancer？[J]. Integr Cancer Ther, 2016, 15(2)：145-152.
|
| [55] |
Hunter CM, Figueiro MG. Measuring light at night and melatonin levels in shift workers: a review of the literature[J]. Biol Res Nurs, 2017, 19(4)：365-374.
|